4//SEC Filing
MIRZA ZIAD 4
Accession 0001415889-18-000534
CIK 0001411879other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:24 PM ET
Size
5.9 KB
Accession
0001415889-18-000534
Insider Transaction Report
Form 4
MIRZA ZIAD
Director
Transactions
- Award
Restricted Stock Units
2018-04-01$0.12/sh+49,059$6,000→ 2,267,217 totalFrom: 2018-04-01Exp: 2028-04-01→ Common Stock (49,059 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock.
- [F2]The Reporting Person was granted a Restricted Stock Unit on April 1, 2018 of 49,059 shares, which were fully vested on the date of the grant. The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the first quarter of 2018 and was valued on March 30, 2018 in accordance with the approved compensation plan for the non-employee members of the Board of Directors.
- [F3]These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan.
Documents
Issuer
INNOVUS PHARMACEUTICALS, INC.
CIK 0001411879
Entity typeother
Related Parties
1- filerCIK 0001538740
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 4:24 PM ET
- Size
- 5.9 KB